Platform technologies: Powering Commercial and Outbreak Development

1:45 PM - 2:45 PM, Wednesday, June 5,2019 ・ 115C, Level 100
This session will focus on the scientific and clinical progress of novel platform technologies. Panelists will share clinical data on current vaccine targets in development and discuss how their platform can be deployed against emerging or unknown pathogens with pandemic or epidemic potential. The group will discuss how to implement policies that invest in these technologies that allow for the dual-use development of vaccines with commercial, emerging infection and outbreak purposes.
Moderator
photo
Vice President, Research Integration & Innovation
International AIDS Vaccine Initiative
Speakers
photo
Senior Vice President, Head of Vaccines Research and Development
GlaxoSmithKline
photo
Vice President, Research Integration & Innovation
International AIDS Vaccine Initiative
photo
SVP Vaccine Partnerships & Health Impact
Moderna Therapeutics
photo
Head of Regulatory Affairs, North America
CEPI (Coalition for Epidemic Preparedness Innovations)
photo
President & Chief Executive Officer
Inovio